OWC Pharmaceutical Research Corp
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis… Read more
OWC Pharmaceutical Research Corp (OWCP) - Total Assets
Latest total assets as of September 2019: $1.77 Million USD
Based on the latest financial reports, OWC Pharmaceutical Research Corp (OWCP) holds total assets worth $1.77 Million USD as of September 2019.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
OWC Pharmaceutical Research Corp - Total Assets Trend (2008–2018)
This chart illustrates how OWC Pharmaceutical Research Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
OWC Pharmaceutical Research Corp - Asset Composition Analysis
Current Asset Composition (December 2018)
OWC Pharmaceutical Research Corp's total assets of $1.77 Million consist of 99.0% current assets and 1.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 97.5% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $37.00K | 1.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2018)
This chart illustrates how OWC Pharmaceutical Research Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: OWC Pharmaceutical Research Corp's current assets represent 99.0% of total assets in 2018, an increase from 90.5% in 2008.
- Cash Position: Cash and equivalents constituted 97.5% of total assets in 2018, up from 78.6% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 9.0% in 2008.
- Asset Diversification: The largest asset category is property, plant & equipment at 1.0% of total assets.
OWC Pharmaceutical Research Corp Competitors by Total Assets
Key competitors of OWC Pharmaceutical Research Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
OWC Pharmaceutical Research Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - OWC Pharmaceutical Research Corp generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - OWC Pharmaceutical Research Corp is currently not profitable relative to its asset base.
OWC Pharmaceutical Research Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.12 | 10.67 | 17.23 |
| Quick Ratio | 3.12 | 10.67 | 17.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.15 Million | $ 3.88 Million | $ 1.31 Million |
OWC Pharmaceutical Research Corp - Advanced Valuation Insights
This section examines the relationship between OWC Pharmaceutical Research Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 42.29 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 234.8% |
| Total Assets | $3.55 Million |
| Market Capitalization | $4.97K USD |
Valuation Analysis
Below Book Valuation: The market values OWC Pharmaceutical Research Corp's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: OWC Pharmaceutical Research Corp's assets grew by 234.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for OWC Pharmaceutical Research Corp (2008–2018)
The table below shows the annual total assets of OWC Pharmaceutical Research Corp from 2008 to 2018.
| Year | Total Assets | Change |
|---|---|---|
| 2018-12-31 | $3.55 Million | +234.85% |
| 2017-12-31 | $1.06 Million | +113.60% |
| 2016-12-31 | $496.77K | +15.41% |
| 2015-12-31 | $430.45K | -71.73% |
| 2014-12-31 | $1.52 Million | +61577.28% |
| 2013-12-31 | $2.47K | -69.52% |
| 2012-12-31 | $8.10K | +2.20% |
| 2011-12-31 | $7.93K | -95.28% |
| 2008-12-31 | $167.81K | -- |